At last, FDA steps up to nanotech issues

No date yet, this report coming out of the recent bio conference in Boston says the FDA committed to holding a public meeting “in the fall” to begin evaluating its options in regard to protecting humans and the earth from the unknown potential dangers of working with nano-sized molecules.

In previous posts about nano, I argue that we can’t let those who stand to benefit immensely at the bottom line be solely in charge of deciding what’s safe or not. And while it’s great to know that some companies are themselves taking responsibility for trying to be safe with nano-developments, it’s gratifying to see the government finally acknowledging it has a major role to play in holding business accountable.